FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.21  |  FHIR Version n/a  User: [n/a]

8940801000001103: Re-introduced (qualifier value)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 01-Oct 2007. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
40298601000001113 Re-introduced (qualifier value) en Fully specified name Active Only initial character case insensitive SNOMED CT United Kingdom drug extension module
40298701000001115 Re-introduced en Synonym Active Only initial character case insensitive SNOMED CT United Kingdom drug extension module

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Re-introduced Is a Non-availability indicator true Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group
Difflam 3mg lozenges lemon (Viatris UK Healthcare Ltd) VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Difflam 3mg lozenges orange-honey (Viatris UK Healthcare Ltd) VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Difflam 3mg lozenges mint (Viatris UK Healthcare Ltd) 20 lozenge VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Difflam 3mg lozenges lemon (Viatris UK Healthcare Ltd) 20 lozenge VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Lozamine 3mg lozenges (Accura Health Ltd) VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Difflam 3mg lozenges eucalyptus (Viatris UK Healthcare Ltd) 20 lozenge VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Difflam 3mg lozenges eucalyptus (Viatris UK Healthcare Ltd) VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Neuropathy sweat detection pads 2 pad VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Metoclopramide 5mg tablets (A A H Pharmaceuticals Ltd) VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Metoclopramide 5mg tablets (A A H Pharmaceuticals Ltd) 28 tablet 2 x 14 tablets VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Iodixanol 550mg/ml (Iodine 270mg/ml) solution for injection 200ml bottles 6 bottle VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Iodixanol 550mg/ml (Iodine 270mg/ml) solution for injection 200ml bottles 10 bottle VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Omnipaque 350 solution for injection 20ml vials (GE Healthcare Biosciences) 25 vial VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Omnipaque 300 solution for injection 20ml vials (GE Healthcare Biosciences) VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Ciprofloxacin 200mg/100ml infusion bags (Bowmed Ibisqus Ltd) 10 bag VMP non-availability indicator False Re-introduced Inferred relationship Existential restriction modifier
Ciprofloxacin 400mg/200ml infusion bags (Bowmed Ibisqus Ltd) 10 bag VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Iohexol 647mg/ml (Iodine 300mg/ml) solution for injection 20ml vials 25 vial VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Omnipaque 350 solution for injection 20ml vials (GE Healthcare Biosciences) VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Omnipaque 300 solution for injection 20ml vials (GE Healthcare Biosciences) 25 vial VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Visipaque 270 solution for injection 200ml bottles (Amersham Health) 6 bottle glass bottle VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Fluconazole 200mg/100ml infusion bags (Bowmed Ibisqus Ltd) 10 bag VMP non-availability indicator False Re-introduced Inferred relationship Existential restriction modifier
Iohexol 755mg/ml (Iodine 350mg/ml) solution for injection 20ml vials 25 vial VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Visipaque 270 solution for injection 200ml bottles (GE Healthcare Ltd) 10 bottle plastic bottle VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Visipaque 270 solution for injection 200ml bottles (Amersham Health) VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Metoclopramide 5mg tablets (Alliance Healthcare (Distribution) Ltd) 28 tablet 2 x 14 tablets VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Iodoform compound paint BPC 1954 VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Chlorpromazine 10mg tablets (A A H Pharmaceuticals Ltd) VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Calcium folinate 200mg/20ml solution for injection vials (Fresenius Kabi Ltd) 10 vial VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Calcium folinate 200mg/20ml solution for injection vials (Fresenius Kabi Ltd) 1 vial VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Calcium folinate 200mg/20ml solution for injection vials (Teva UK Ltd) 1 vial VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Rupatadine 10mg tablets (DE Pharmaceuticals) 30 tablet VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Iodoform compound paint BPC 1954 (Special Order) 1 ml VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Iodoform compound paint BPC 1954 (J M Loveridge Plc) 500 ml VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Iodoform compound paint BPC 1954 100 ml VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Iodoform compound paint BPC 1954 500 ml VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Levothyroxine sodium 100micrograms/5ml oral solution sugar free (Zentiva Pharma UK Ltd) 100 ml VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Prednisolone 20mg/application foam enema (DE Pharmaceuticals) VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Iodoform compound paint BPC 1954 (J M Loveridge Plc) VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Iodoform compound paint BPC 1954 (A A H Pharmaceuticals Ltd) 100 ml VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Prednisolone 20mg/application foam enema (DE Pharmaceuticals) 14 dose VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Bimatoprost 300micrograms/ml eye drops (A A H Pharmaceuticals Ltd) 3 ml VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Trihexyphenidyl 5mg/5ml oral solution (DE Pharmaceuticals) 200 ml VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Rupatadine 10mg tablets (DE Pharmaceuticals) VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Iodoform compound paint BPC 1954 (A A H Pharmaceuticals Ltd) VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Iodoform compound paint BPC 1954 (A A H Pharmaceuticals Ltd) 500 ml VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Bimatoprost 300micrograms/ml eye drops (A A H Pharmaceuticals Ltd) VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Trihexyphenidyl 5mg/5ml oral solution (DE Pharmaceuticals) VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Iodoform compound paint BPC 1954 1 ml VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Iodoform compound paint BPC 1954 (J M Loveridge Plc) 100 ml VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Iodoform compound paint BPC 1954 (Special Order) VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Levothyroxine sodium 100micrograms/5ml oral solution sugar free (Zentiva Pharma UK Ltd) VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Calcium folinate 200mg/20ml solution for injection vials 10 vial VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Calcium folinate 200mg/20ml solution for injection vials (Fresenius Kabi Ltd) VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Calcium folinate 350mg/35ml solution for injection vials (Fresenius Kabi Ltd) 1 vial VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Chlorpromazine 10mg tablets (A A H Pharmaceuticals Ltd) 28 tablet 2 x 14 tablets VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Phyto-K 10mg tablets (TriOn Pharma Ltd) 28 tablet 2 x 14 tablets VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Calcium folinate 200mg/20ml solution for injection vials 1 vial VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
SynBio L-Arginine 500mg capsules (Synergy Biologics Ltd) 60 capsule 6 x 10 capsules VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
SynBio L-Arginine 500mg capsules (Synergy Biologics Ltd) VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Co-trimoxazole 40mg/200mg/5ml oral suspension sugar free (DE Pharmaceuticals) 100 ml VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Co-trimoxazole 40mg/200mg/5ml oral suspension sugar free (DE Pharmaceuticals) VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Mexiletine 50mg capsules (A A H Pharmaceuticals Ltd) VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Calcium folinate 200mg/20ml solution for injection vials (Teva UK Ltd) VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Diphencyprone 0.5% in acetone liquid VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Mexiletine 50mg capsules (Alliance Healthcare (Distribution) Ltd) VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Metoclopramide 5mg tablets (Alliance Healthcare (Distribution) Ltd) VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Diphencyprone 0.5% in acetone liquid (Special Order) 100 ml VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Diphencyprone 0.5% in acetone liquid 5 ml VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Diphencyprone 0.5% in acetone liquid 1 ml VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Diphencyprone 0.5% in acetone liquid (Special Order) 1 ml VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Diphencyprone 0.5% in acetone liquid (Special Order) 5 ml VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Diphencyprone 0.5% in acetone liquid 100 ml VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Diphencyprone 0.5% in acetone liquid (Special Order) VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Oxaliplatin 200mg/40ml concentrate for solution for infusion vials (Consilient Health Ltd) 1 vial VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Doxepin 10mg capsules (Morningside Healthcare Ltd) 28 capsule 2 x 14 capsules VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Etoposide 500mg/25ml concentrate for solution for infusion vials (Consilient Health Ltd) 1 vial VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Doxepin 10mg capsules (Morningside Healthcare Ltd) VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Etoposide 500mg/25ml concentrate for solution for infusion vials (Consilient Health Ltd) VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Doxepin 25mg capsules (Morningside Healthcare Ltd) 28 capsule 2 x 14 capsules VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Doxepin 10mg capsules 28 capsule VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Oxaliplatin 200mg/40ml concentrate for solution for infusion vials (Consilient Health Ltd) VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Doxepin 50mg capsules (Morningside Healthcare Ltd) VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Doxepin 25mg capsules (Morningside Healthcare Ltd) VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Doxepin 50mg capsules (Morningside Healthcare Ltd) 28 capsule 2 x 14 capsules VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Mexiletine 50mg capsules (Alliance Healthcare (Distribution) Ltd) 84 capsule 6 x 14 capsules VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Phytomenadione 10mg tablets 28 tablet VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Antithrombin III 1,000unit powder and solvent for solution for infusion vials (Imported (Austria)) VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Kybernin P 1,000unit powder and solvent for solution for infusion vials (Imported (Germany)) VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Kybernin P 1,000unit powder and solvent for solution for infusion vials (Imported (Germany)) 1 vial VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Antithrombin III 1,000unit powder and solvent for solution for infusion vials 1 vial VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Antithrombin III 1,000unit powder and solvent for solution for infusion vials (Imported (Austria)) 1 vial VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Vapour-permeable adhesive film dressing 10cm x 14cm VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Hypodermic U100 insulin syringe sterile single use / single patient use 0.3ml with 12mm needle 0.33mm/29gauge VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Hydrocolloid dressing semi-permeable sterile with adhesive border 15cm x 18cm sacral VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Activated charcoal absorbent dressing 10cm x 25cm VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Abiraterone 250mg tablets 120 tablet VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Mexiletine 50mg capsules (A A H Pharmaceuticals Ltd) 84 capsule VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Soft silicone wound contact dressing sterile 20cm x 30cm VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Doxepin 50mg capsules (Roma Pharmaceuticals Ltd) VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Doxepin 50mg capsules (Roma Pharmaceuticals Ltd) 28 capsule VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Xaqua 5mg tablets (Renascience Pharma Ltd) VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier

Start Previous Page 4 of 86 Next End

This concept is not in any reference sets

Back to Start